Target intelligence / Profile preview

microRNA 6503 (MIR6503)

Target: MIR6503
Molecular classification: microRNA

Overview

MicroRNA 6503 (MIR6503, hsa-mir-6503) is a human microRNA belonging to the class of small, non-coding RNAs that regulate gene expression by post-transcriptional silencing mechanisms, typically through binding to complementary sequences in target messenger RNAs[3][5]. Editing events in hsa-mir-6503 have been detected in blood cancer subtypes, notably in chronic lymphocytic leukemia (CLL) cell samples, though functional characterization and therapeutic relevance remain unestablished[1].

Other names: hsa-mir-6503microRNA mir-6503MIR6503

Biological functions

post-transcriptional gene silencinggene expression regulation

Disease associations

potential role in leukemia (editing sites described in leukemia subtypes)[1]

Beyond the preview

Go deeper on microRNA 6503 (MIR6503).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 6503 (MIR6503).

Explore the full profile